Owner Immunex Corporation

Inventors Born, Teresa L; Smith, Dirk E; Sims, John E

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004218668

Parent 775128

Filing date 7 October 2004

Wipo publication date 4 November 2004

Acceptance publication date 5 July 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/25 (2006.01) Mutation or genetic engineering

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies